Страна: Португалия
Язык: английский
Источник: HMA (Heads of Medicines Agencies)
enrofloxacin 100 mg/ml
Pfizer Limited
QM01AC06
Solution for injection
meloxicam
Cattle, Pigs
2011-12-21
AN: 01749/2010 Issued: February 2012 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Reneval 100 mg/ml Solution for Injection for cattle and pigs. Reneval (DK) Reneval vet. 100 mg/ml Solution for Injection for cattle and pigs. (FI, SE) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of solution contains: Active substance Enrofloxacin 100.0 mg Excipients n-Butanol 30.0 mg For full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection Clear light yellow solution free from particulate matter. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _Cattle _ Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. _pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia _and_ _ _salmonellosis_) and secondary bacterial infections subsequent to viral infections (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. AN: 01749/2010 Issued: February 2012 Page 2 of 8 Treatment of local signs (inflammation, milk quality and yield) associated with peracute/acute mastitis in lactating dairy cattle caused by E. coli, where herd history and previous sensitivity testing indicate enrofloxacin as the drug of choice. _ _ _Pigs _ _ _ Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. _pasteurello Прочитать полный документ